3 antibody, {TAIL ~ an anti glypican 3 antibody} having a modulated plasma half life and a pharmaceutical composition comprising the antibody as an active ingredient, as well as a method of preparing the anti glypican 3 antibody and {HEAD ~ the pharmaceutical composition} 
3 antibody , { TAIL ~ an anti glypican 3 antibody } having a modulated plasma half life and a pharmaceutical composition comprising the antibody as an active ingredient , as well as a method of preparing the anti glypican 3 antibody and { HEAD ~ the pharmaceutical composition }
OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD